United States · FDA National Drug Code directory

Female Liquescence

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
83027-0146_71bb6526-1677-4aaf-97ca-aec5bdf7fad9
Product NDC
83027-0146
Form
LIQUID
Composition / generic term
Dioscorea Villosa, Glycyrrhiza Glabra, Hamamelis Virginiana, Rubus Idaeus, Viburnum Opulus, Caulophyllum Thalictroides, Estradiol, Oophorinum (Suis), Progesterone, Uterus (Suis), Human Growth Hormone (HGH), Ignatia Amara
Labeler
Nutritional Specialties, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20240925
Source listing expiry
20261231

Source-listed ingredients

  • DIOSCOREA VILLOSA TUBER — 2 [hp_X]/mL
  • GLYCYRRHIZA GLABRA — 2 [hp_X]/mL
  • HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK — 2 [hp_X]/mL
  • RUBUS IDAEUS LEAF — 2 [hp_X]/mL
  • VIBURNUM OPULUS BARK — 2 [hp_X]/mL
  • CAULOPHYLLUM THALICTROIDES ROOT — 3 [hp_X]/mL
  • ESTRADIOL — 6 [hp_X]/mL
  • SUS SCROFA OVARY — 6 [hp_X]/mL
  • PROGESTERONE — 6 [hp_X]/mL
  • SUS SCROFA UTERUS — 6 [hp_X]/mL
  • SOMATROPIN — 12 [hp_X]/mL
  • STRYCHNOS IGNATII SEED — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 120 mL in 1 BOTTLE, GLASS (83027-0146-1) · 83027-0146-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →